Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription 29.09.2025 1 Am J Med 1 Biochem Biophys Res Commun 1 J Gen Virol 10 J Infect Dis 12 J Virol 2 PLoS Comput Biol 1 PLoS Med 16 PLoS One 1 Proc Natl Acad Sci U S A 5 Vaccine 4 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. WAHID L, Kwon T, Kreuziger LB, Kasthuri RS, et al
   Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge is Not Associated with Improvement in Quality of Life.
   Am J Med. 2025;138:1464-1468.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. ZHANG L, Li Y, Ye K, Wang P, et al
   Article I. metformin affects H1N1-induced apoptosis in lung epithelial cells by the miR-130a-5p-regulated PI3K/AKT signaling pathway.
   Biochem Biophys Res Commun. 2025;782:152526.
   PubMed         Abstract available
   
   

   
   J Gen Virol

3. HA Y, Lee YH, Jo HS, Kwon TW, et al
   Susceptibility of different mouse strains to SARS-CoV-2 spike receptor-binding domain protein-induced lung inflammation: a comparative study.
   J Gen Virol. 2025;106.
   PubMed         Abstract available
   
   

   
   J Infect Dis

4. GAILLET A, Layese R, Fourati S, Celante H, et al
   Clinical Phenotypes and Outcomes Associated With Respiratory Syncytial Virus Infection in Critically Ill Patients: A Retrospective Multicenter Cohort Study in Greater Paris Area Hospitals, 2017-2023.
   J Infect Dis. 2025;232:679-690.
   PubMed         Abstract available
   
   
5. LI K, Bont LJ, Weinberger DM, Pitzer VE, et al
   Relating In Vivo Respiratory Syncytial Virus Infection Kinetics to Host Infectiousness in Different Age Groups.
   J Infect Dis. 2025;232:691-699.
   PubMed         Abstract available
   
   
6. LI K, Pitzer VE, Weinberger DM
   Exploring RSV Transmission Patterns in Different Age Groups in the United States.
   J Infect Dis. 2025;232:700-708.
   PubMed         Abstract available
   
   
7. DOSS CR, Osborn MJ, Stark S, Rhein J, et al
   Wastewater Measures of SARS-CoV-2 Accurately Predict Frequency of Symptomatic Infections in the Community.
   J Infect Dis. 2025;232:e459-e465.
   PubMed         Abstract available
   
   
8. HAMILTON F, Butler-Laporte G, Davey Smith G
   Mendelian Randomization and Infection: Pitfalls and Promises.
   J Infect Dis. 2025;232:525-533.
   PubMed         Abstract available
   
   
9. WANG C, Yuan HY, Lau EHY, Cowling BJ, et al
   Impact of Population Immunity and Public Health Measures on the Transmission of Omicron Subvariants BA.2 and BA.5 in Hong Kong.
   J Infect Dis. 2025;232:e476-e485.
   PubMed         Abstract available
   
   
10. KNOX JJ, Lee I, Blumberg EA, Rosenfeld AM, et al
    B-Cell Subset Representation Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant Recipients.
    J Infect Dis. 2025 Jun 3:jiaf250. doi: 10.1093.
    PubMed         Abstract available
    
    
11. LIM SY, Lee J, Kwon JS, Chang E, et al
    Disparate kinetics of viable virus shedding in immunocompromised patients: SARS-CoV-2 versus influenza virus - a prospective real-world cohort study.
    J Infect Dis. 2025 Sep 15:jiaf479. doi: 10.1093.
    PubMed         Abstract available
    
    
12. ALEMNJI G, Sangthong A, Espy N, Bartee M, et al
    PEPFAR Laboratory Implementation Strategy as a Component of PEPFAR's 5-Year Strategy.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    
13. OKOYE M, Okoi C, Espy N, Mba N, et al
    Leveraging PEPFAR- and Global Fund-Supported Laboratory Network for Integrated Disease Testing: Lessons From Integrated HIV, Tuberculosis, and COVID-19 Testing in Nigeria.
    J Infect Dis. 2025;232.
    PubMed         Abstract available
    
    

    
    J Virol

14. MA Y, Ye C, Khalil AM, Mahmoud SH, et al
    A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants.
    J Virol. 2025 Aug 7:e0082125. doi: 10.1128/jvi.00821.
    PubMed         Abstract available
    
    
15. KARIMI A, Lieber CM, Sakamoto K, Plemper RK, et al
    SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters.
    J Virol. 2025 Aug 11:e0075525. doi: 10.1128/jvi.00755.
    PubMed         Abstract available
    
    
16. BATY JJ, Drozdick AK, Pfeiffer JK
    Pseudomonas aeruginosa rhamnolipids stabilize human rhinovirus 14 virions.
    J Virol. 2025;99:e0093125.
    PubMed         Abstract available
    
    
17. HU J, Zheng H, Ran W, Wang X, et al
    Mucosal vaccination with long-form TSLP induces migratory cDC1-mediated adaptive immunity against SARS-CoV-2 infection.
    J Virol. 2025 Aug 19:e0123125. doi: 10.1128/jvi.01231.
    PubMed         Abstract available
    
    
18. EL ZOWALATY ME, Taylor LJ, Son Y, Lee H, et al
    Discovery, phylogenetic, and comparative genomic analysis of novel avian gammacoronaviruses identified in feral pigeons (Columba livia domestica).
    J Virol. 2025 Aug 20:e0111225. doi: 10.1128/jvi.01112.
    PubMed         Abstract available
    
    
19. ZHANG H, Deng X, Dai R, Fu J, et al
    Inadequate immune response to inactivated COVID-19 vaccine among older people living with HIV: a prospective cohort study.
    J Virol. 2025 Aug 21:e0068825. doi: 10.1128/jvi.00688.
    PubMed         Abstract available
    
    
20. CHI X, Liang X, Vaddadi K, Zhang X, et al
    SARS-CoV-2 Nsp15 endoribonuclease subverts host defenses to enhance viral fitness in lung cells.
    J Virol. 2025 Aug 21:e0117525. doi: 10.1128/jvi.01175.
    PubMed         Abstract available
    
    
21. HU Z, Tian S, Zhou Y, Wang Y, et al
    Nanoparticle vaccine based on the pre-fusion F glycoprotein of respiratory syncytial virus elicits robust protective immune responses.
    J Virol. 2025 Aug 26:e0090325. doi: 10.1128/jvi.00903.
    PubMed         Abstract available
    
    
22. VERMA A, Kamboj H, Kumar G, Khandelwal N, et al
    TGF-beta inhibitor SB431542 suppresses SARS-CoV-2 replication through multistep inhibition.
    J Virol. 2025 Aug 29:e0052925. doi: 10.1128/jvi.00529.
    PubMed         Abstract available
    
    
23. GRACIE NP, Aggarwal A, Luo R, Spicer M, et al
    An RGD motif on SARS-CoV-2 Spike induces TGF-beta signaling and downregulates interferon.
    J Virol. 2025 Sep 4:e0043525. doi: 10.1128/jvi.00435.
    PubMed         Abstract available
    
    
24. JANZEN GM, Inderski BT, Chang J, Arendsee ZW, et al
    Sources and sinks of influenza A virus genomic diversity in swine from 2009 to 2022 in the United States.
    J Virol. 2025;99:e0054125.
    PubMed         Abstract available
    
    
25. ZHU B, Fung K, Feng HH, Beatty JA, et al
    The hemagglutinin proteins of clades 1 and 2.3.4.4b H5N1 highly pathogenic avian influenza viruses exhibit comparable attachment patterns to avian and mammalian tissues.
    J Virol. 2025 Sep 23:e0097625. doi: 10.1128/jvi.00976.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

26. LIM D, Ko KT, Hong H, Lee H, et al
    A history-dependent approach for accurate initial condition estimation in epidemic models.
    PLoS Comput Biol. 2025;21:e1013438.
    PubMed         Abstract available
    
    
27. HODGSON D, Hay J, Jarju S, Jobe D, et al
    serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data.
    PLoS Comput Biol. 2025;21:e1013467.
    PubMed         Abstract available
    
    

    
    PLoS Med

28. PREISS A, Bhatia A, Aragon LV, Baratta JM, et al
    Effect of Paxlovid treatment during acute COVID-19 on Long COVID onset: An EHR-based target trial emulation from the N3C and RECOVER consortia.
    PLoS Med. 2025;22:e1004711.
    PubMed         Abstract available
    
    

    
    PLoS One

29. SALDIVAR L, Rajabi T, Li W, Lopa S, et al
    Recurrent venous thromboembolism and clot distribution in COVID-19 infection: A review by variant type.
    PLoS One. 2025;20:e0331283.
    PubMed         Abstract available
    
    
30. SAW HW, Kapteyn A
    Personality traits, panel tenure, survey topic, and context as predictors of survey nonresponse patterns in high-frequency online longitudinal surveys.
    PLoS One. 2025;20:e0332902.
    PubMed         Abstract available
    
    
31. BASHORUN AO, Kotei L, Jallow AF, Jawla O, et al
    Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocol.
    PLoS One. 2025;20:e0332842.
    PubMed         Abstract available
    
    
32. SHIMIZU IS, Freire SF, Sousa MLA, Ferreira JC, et al
    Knowledge, attitudes, and practice about protective ventilation among physical therapists.
    PLoS One. 2025;20:e0331949.
    PubMed         Abstract available
    
    
33. LU W, Liu Q, Li H
    Confidence, animal spirits, and the macroeconomy in China: Based on mixed-frequency data models.
    PLoS One. 2025;20:e0332909.
    PubMed         Abstract available
    
    
34. WANG J, Liu Y, Li N, Zhu Y, et al
    Hand hygiene after the COVID-19 pandemic: Is it still at a high level?
    PLoS One. 2025;20:e0332634.
    PubMed         Abstract available
    
    
35. EDU-QUANSAH DA, Bandoh DA, Edu-Quansah EP, Appiah AB, et al
    Evaluation of the performance of the Influenza-like Illness (ILI) surveillance system in the Okai Koi North District, Greater Accra Region, 2022.
    PLoS One. 2025;20:e0332334.
    PubMed         Abstract available
    
    
36. BOEVER C, Zech E, Arcand L, Verdon C, et al
    What does it mean to have experienced the death of a relative in a context of social and funeral restrictions? Lessons from the pandemic for bereavement research and clinical practice.
    PLoS One. 2025;20:e0331946.
    PubMed         Abstract available
    
    
37. SWANSON B, Bishop-Royse J, Keshavarzian A, Balk R, et al
    Examination of unique volatile organic compound signatures in nasopharyngeal test swab viral transport media using an electronic nose.
    PLoS One. 2025;20:e0332399.
    PubMed         Abstract available
    
    
38. REITERMAN M, Chin AI, Bang H
    Adverse outcomes post-COVID-19 hospitalization among ESRD patients: A retrospective cohort study in 5 California university medical centers.
    PLoS One. 2025;20:e0332203.
    PubMed         Abstract available
    
    
39. PAYNE LA, Edelman A, Darney BG, Benhar E, et al
    Brief report: Older adolescents and young adults may be at higher risk for changes to menstrual cycle length with COVID-19 vaccination.
    PLoS One. 2025;20:e0331346.
    PubMed         Abstract available
    
    
40. POLISHCHUK V, Kostinov capital EM, Cyrillic, Ryzhov capital A, Cyrillic, Dagil Y, et al
    Immunogenicity of one dose and two doses of adjuvanted influenza vaccine in lung transplant candidates.
    PLoS One. 2025;20:e0332346.
    PubMed         Abstract available
    
    
41. PEREZ-MORALES AM, Jimenez-Juarez RN, Morales-Rios OM, Reyes-Lopez A, et al
    Antibacterial consumption before, during, and after the COVID-19 pandemic in a tertiary care pediatric hospital in Mexico.
    PLoS One. 2025;20:e0329220.
    PubMed         Abstract available
    
    
42. KAYA MG, Karaman K
    Clinical parameters associated with mortality in elderly patients with COVID-19.
    PLoS One. 2025;20:e0332800.
    PubMed         Abstract available
    
    
43. MONGE M, Hurtado R, Infante J
    Time trends and persistence of the return difference between growth and value investment strategies.
    PLoS One. 2025;20:e0332690.
    PubMed         Abstract available
    
    
44. WANG Y, Gao YD, Jiang CH, Xi Y, et al
    Characterisation of a novel chicken-derived H3N3 avian influenza virus detected in China in 2023: Pathogenicity and immunogenicity.
    PLoS One. 2025;20:e0332213.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

45. YOSHIDA A, Uekusa Y, Suzuki T, Bauer M, et al
    Enhanced visualization of influenza A virus entry into living cells using virus-view atomic force microscopy.
    Proc Natl Acad Sci U S A. 2025;122:e2500660122.
    PubMed         Abstract available
    
    

    
    Vaccine

46. SCHERM MJ, Holzl R, Gonzalez-Dominguez I, Hjorth R, et al
    Assessment of critical bioprocess parameters for broadly cross-reactive chimeric hemagglutinin influenza virus vaccines.
    Vaccine. 2025;64:127671.
    PubMed         Abstract available
    
    
47. HARIT D, Sawant S, Spreng RL, Gurley S, et al
    Qualification of a reporter virus microneutralization assay for evaluation of influenza specific antibodies in human clinical trials.
    Vaccine. 2025;64:127699.
    PubMed         Abstract available
    
    
48. HUI S, He R, Li H, Li Y, et al
    Revealing dynamic transcriptomic and immune cell signatures underlying heterogeneous responses to influenza vaccination.
    Vaccine. 2025;64:127777.
    PubMed         Abstract available
    
    
49. PALACHE B, Fyyaz H, Thomson D, Taylor B, et al
    The IFPMA IVS seasonal influenza vaccine dose distribution survey 2022-2023: evidence of the need for committed national investment in and uptake of seasonal influenza vaccination.
    Vaccine. 2025;64:127747.
    PubMed         Abstract available
    
    
50. SARTORI AL, Buffarini R, Bertoldi AD, da Silveira MF, et al
    Association between maternal influenza vaccination and childhood vaccination among participants of the 2015 Pelotas (Brazil) birth cohort.
    Vaccine. 2025;64:127761.
    PubMed         Abstract available
    
    

    
    Virus Res

51. SHI X, Wang J, Li C, Du S, et al
    Single amino acid substitution at position 614 in SARS-CoV-2 Spike Protein alters viral assembly and infectivity.
    Virus Res. 2025;360:199624.
    PubMed         Abstract available
    
    
52. GONG T, Zhang X, Lin H, Li J, et al
    Mutation profiling, evolution analysis, molecular dynamics simulation, and functional characterization of Omicron sub-strains.
    Virus Res. 2025;360:199626.
    PubMed         Abstract available
    
    
53. RAMASAMY S, Bustamante F, LaBella LC, Cole SD, et al
    Spillover of SARS-CoV-2 to domestic dogs in COVID-19-positive households: A one health surveillance study.
    Virus Res. 2025;360:199629.
    PubMed         Abstract available
    
    
54. CHAVOIX C, Massin P, Briand FX, Louboutin K, et al
    Identification of H1N2 influenza viruses in turkeys after spillover from swine and in vitro characterization.
    Virus Res. 2025 Sep 21:199634. doi: 10.1016/j.virusres.2025.199634.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.